| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5997035 | Progress in Pediatric Cardiology | 2015 | 5 Pages |
Abstract
The world population is aging and 60% of all cancer diagnoses and 70% of all cancer mortality occur in patients greater than 65Â years of age. The elderly have multiple medical and non-medical comorbidities that accompany changes in pharmacokinetics and pharmacodynamics and poly-pharmacy that all impact their treatment. The elderly derive benefit from cancer treatment but are often denied chemotherapy or are undertreated based on age. Treatment decision should be based on physiologic rather than chronological age and there is a need for inclusion of more elderly patients in cancer clinical trials.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Joseph R. Carver,